AKRX - Akorn, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Akorn, Inc.

1925 West Field Court
Suite 300
Lake Forest, IL 60045
United States

IndustryDrugs - Generic
Full Time Employees2,261

Key Executives

Mr. Rajat RaiChief Exec. Officer2.06MN/A50
Mr. Duane A. PortwoodChief Financial Officer and Exec. VP995.9kN/A51
Dr. Bruce Kutinsky Pharm.D.Chief Operating Officer841.36k11.6M51
Mr. Joseph BonaccorsiExec. VP, Gen. Counsel and Sec.777.76k5.37M52
Mr. Jonathan KaferExec. VP of Sales and Marketing474.19kN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Akorn, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets specialized generic and branded pharmaceuticals, over-the-counter (OTC) drug products, and animal health products in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. This segment’s primary products include Atropine Sulfate Ophthalmic Solution; Clobetasol Propionate Cream And Ointment; Ephedrine Sulfate Injection; Lidocaine Ointment; Methylene Blue Injection; Myorisan soft gelatin capsules; Nembutal sodium solution; Phenylephrine Hydrochloride Ophthalmic Solution; and Zioptan tafluprost ophthalmic solution. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products, including Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. The company was founded in 1971 and is headquartered in Lake Forest, Illinois.

Corporate Governance

Akorn, Inc.’s ISS Governance QualityScore as of December 1, 2017 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 6; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.